ANOS1 and cryptorchidism: In alignment with previous reports (Dwyer et al., 2024), our data demonstrate that patients with cryptorchidism, absent spontaneous puberty, low baseline inhibin B, and pathogenic ANOS1 variants such as in the KS subgroup of our cohort, require a longer duration of combined gonadotropins and do not achieve as high TV as those with less severe disease.